Ambergen

Ambergen is a privately-held biotechnology company that is developing a new generation of diagnostic tests.

Ambergen's proprietary molecular profiling technology enables physicians to more accurately make optimal therapeutic decisions tailored to individual patients. This is made possible by identifying unique molecular fingerprints in tumors, blood and other biospecimens that are characteristic of specific diseases and their outcomes. Ambergen approach combines unique patented technology in the area of proteomics, genomics and bioinformatics.